|Bid||4,695.00 x 54200|
|Ask||4,800.00 x 67200|
|Day's range||4,718.50 - 4,784.00|
|52-week range||2,879.89 - 5,643.60|
|PE ratio (TTM)||19.17|
|Dividend & yield||2.16 (3.59%)|
|1y target est||5,734.71|
Should you follow Neil Woodford and sell GlaxoSmithKline plc (LON: GSK) and British American Tobacco plc (LON: BATS)?
Royston Wild explains looks at another London-quoted stock standing on shaky ground like British American Tobacco plc (LON: BATS).
Tobacco company Philip Morris International amassed an order book of US$2.4bn for its US$1.25bn investment-grade bond deal on Monday, leaving the trade slightly less than twice covered. The sector's second deal in as many weeks - after the recent US$17.25bn offering from rival British American Tobacco (Kuala Lumpur: 4162.KL - news) - left some feeling oversupplied, one bond buyer said. "We just had a big tobacco deal," he told IFR.